BIO Protocol

United States
Troy, New Hampshire, United States

Company profile

BIO Protocol company profile

The BIO Protocol (BIO) allows onchain scientific communities to fund, build, and co-own research and products in specific biomedical domains including lifespan, brain health, and rare disorders. BIO, founded by senior VitaDAO members, empowers worldwide communities of scientists, patients, and investors to take science into their own hands and bring solutions to life more effectively than traditional pharmaceutical companies.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2022-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$6.9M
Last funding
Seed / $6.9M / 2025-09-17
Last equity funding
Seed / $6.9M
Investors
21
Lead investors
2
Articles
21

Founders and investors

Lead investors

MaelstromYZi Labs

Investors

Animoca BrandsBig Brain HoldingsMaelstromMiranaYZi Labs